← Eichor
Study identifier: NCT04356664 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis

Condition: Endometriosis · Adenomyosis · Infertility, Female  ·  Sponsor: Hopital Foch

PhasePhase 2/Phase 3
Planned participants180
Who can joinFemale, 18 Years to 36 Years
Healthy volunteersNo

About this study

Women suffering from endometriosis and/or adenomyosis may also suffer from infertility. GnRH agonist injection could improve implantation and therefore increase the pregnancy rate in these patients. This study was designed to evaluate effects of the additional of GnRH agonist (single or 2 doses) to the routine oestrogens and progestins use as support before Frozen Embryon Transfer as compared to oestrogens and progestins only.

This description comes directly from the study's public registry record.

Talk to the study team

Elisabeth Hulier-Ammar, Dr  ·  0033146251175  ·  e.hulier-ammar@hopital-foch.com

Always discuss trial participation with your own doctor first.

Locations (1)

Hopital FochSuresnes, FranceRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04356664